The US Food and Drug Administration (FDA) has granted clearance to SpliceBio’s investigational new drug (IND) application to begin the trial of a protein splicing gene therapy, SB-007, designed for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback